BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19735218)

  • 1. Treatment of septic shock and use of drotrecogin alfa (activated) in children.
    Marraro GA
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):769-72. PubMed ID: 19735218
    [No Abstract]   [Full Text] [Related]  

  • 2. Drotrecogin alfa (activated) in an infant with gram-negative septic shock.
    Sajan I; Da-Silva SS; Dellinger RP
    J Intensive Care Med; 2004; 19(1):51-5. PubMed ID: 15035755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Re-administration of drotrecogin alfa activated in a patient with episodes of severe sepsis].
    Verdú MT; Sánchez OJ
    Rev Esp Anestesiol Reanim; 2007 Dec; 54(10):637-8. PubMed ID: 18201006
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient.
    Huston JM; Eachempati SR; Rodney JR; Cayci C; Fusco D; Mathew M; Shou J; Goldstein MJ; Kapur S; Barie PS
    Transpl Infect Dis; 2009 Jun; 11(3):277-80. PubMed ID: 19392733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drotrecogin alfa (activated) for the treatment of meningococcal purpura fulminans.
    Bachli EB; Vavricka SR; Walter RB; Leschinger MI; Maggiorini M
    Intensive Care Med; 2003 Feb; 29(2):337. PubMed ID: 12594601
    [No Abstract]   [Full Text] [Related]  

  • 6. Activated recombinant protein C in septic shock early after liver transplantation: a case report.
    Feltracco P; Bortolato A; Rizzi S; Barbieri S; Furnari M; Serra E; Milevoj M; Ori C
    Transplant Proc; 2008; 40(6):2070-2. PubMed ID: 18675133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel use for drotrecogin alfa (activated): successful treatment of septic shock associated with coccidioidomycosis.
    Crum NF; Groff HL; Parrish JS; Ring W
    Clin Infect Dis; 2004 Dec; 39(11):e122-3. PubMed ID: 15578351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activated protein C in patients with septic shock: pro].
    Marx G
    Dtsch Med Wochenschr; 2010 Nov; 135(47):2370. PubMed ID: 21082530
    [No Abstract]   [Full Text] [Related]  

  • 9. [Activated protein C in patients with septic shock: contra].
    Graf J
    Dtsch Med Wochenschr; 2010 Nov; 135(47):2371. PubMed ID: 21082531
    [No Abstract]   [Full Text] [Related]  

  • 10. Drotrecogin alfa: a second look. More clinical trials in severe sepsis: mostly negative results.
    Prescrire Int; 2007 Feb; 16(87):7-9. PubMed ID: 17323514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroids and human recombinant activated protein C for septic shock.
    Colin G; Annane D
    Clin Chest Med; 2008 Dec; 29(4):705-12, x. PubMed ID: 18954704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human activated protein C treatment of septic shock syndrome in a patient at 18th week of gestation: a case report.
    Medve L; Csitári IK; Molnár Z; László A
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):864-5. PubMed ID: 16150290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative septic shock.
    Jenkins I
    Cleve Clin J Med; 2006 Jul; 73(7):607; author reply 607-8. PubMed ID: 16845972
    [No Abstract]   [Full Text] [Related]  

  • 14. Drotrecogin alfa (activated) treatment in a neonate with sepsis and multi organ failure.
    Albuali WH; Singh RN; Fraser DD; Scott LA; Kornecki A
    Saudi Med J; 2005 Aug; 26(8):1289-92. PubMed ID: 16127532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drotrecogin alfa (activated) for the treatment of severe sepsis and septic shock.
    Rice TW; Bernard GR
    Am J Med Sci; 2004 Oct; 328(4):205-14. PubMed ID: 15486535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drotrecogin alfa (activated) for nonmenstrual toxic shock syndrome associated with methicillin resistant Staphylococcus aureus infection.
    Haddadin DW; Samnani IQ; Moorman JP
    South Med J; 2006 Nov; 99(11):1295-6. PubMed ID: 17195430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drotrecogin alpha (activated) in neonatal septic shock.
    Frommhold D; Birle A; Linderkamp O; Zilow E; Pöschl J
    Scand J Infect Dis; 2005; 37(4):306-8. PubMed ID: 15804668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Xigris--activated protein C].
    Tønnesen EK
    Ugeskr Laeger; 2004 Mar; 166(11):1002-4. PubMed ID: 15049235
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of activated protein C in a case of paediatric septic shock.
    Verre M; Barozzi E; Piccirillo M; Tancioni F; Tiburzi S; Varano M
    Minerva Pediatr; 2005 Dec; 57(6):429-32. PubMed ID: 16402015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drotrecogin alpha (activated) in septic shock after lung transplant.
    Feltracco P; Rea F; Ori C
    J Heart Lung Transplant; 2008 Jul; 27(7):815. PubMed ID: 18582817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.